Rhumbline Advisers Mannkind Corp Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Mannkind Corp stock. As of the latest transaction made, Rhumbline Advisers holds 449,262 shares of MNKD stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
449,262
Previous 399,033
12.59%
Holding current value
$2.54 Million
Previous $2.01 Million
16.29%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding MNKD
# of Institutions
248Shares Held
161MCall Options Held
1.24MPut Options Held
183K-
Black Rock Inc. New York, NY22.6MShares$127 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$103 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$60.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$43 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY7.01MShares$39.6 Million4.77% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.45B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...